dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversidade Estadual de Campinas (UNICAMP)
dc.date.accessioned2019-10-06T16:46:29Z
dc.date.accessioned2022-12-19T18:57:04Z
dc.date.available2019-10-06T16:46:29Z
dc.date.available2022-12-19T18:57:04Z
dc.date.created2019-10-06T16:46:29Z
dc.date.issued2019-01-01
dc.identifierAmerican Journal of Tropical Medicine and Hygiene, v. 101, n. 3, p. 605-607, 2019.
dc.identifier0002-9637
dc.identifierhttp://hdl.handle.net/11449/189621
dc.identifier10.4269/ajtmh.18-0650
dc.identifier2-s2.0-85071899680
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5370659
dc.description.abstractChagas disease is a public health problem caused by the Trypanosoma cruzi, and the T. cruzi I (TcI) and T. cruzi II (TcII) groups are considered important genotypes from the clinical point of view. Currently, the groups need to be molecularly analyzed for their identification; thus, we cytogenetically analyzed these groups with the objective of developing more accessible techniques for the characterization of these parasites. TcI and TcII groups were differentiated by nucleus characterization with lacto-acetic orcein (TcI—nucleus with positive heteropycnosis and TcII—nucleus with negative heteropycnosis), emphasizing the importance of the application of this technique for epidemiological and clinical studies of Chagas disease.
dc.languageeng
dc.relationAmerican Journal of Tropical Medicine and Hygiene
dc.rightsAcesso restrito
dc.sourceScopus
dc.titleCytotaxonomy of trypanosoma cruzi (Chagas, 1909): Differentiation of T. Cruzi I (TcI) and T. Cruzi II (TcII) genotypes using cytogenetic markers
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución